As a dual action medication that promotes a synergistic response, Combihale (ipratropium bromide and salbutamol) is recommended for the treatment of bronchospasm (airway narrowing) in patients with asthma and chronic obstructive pulmonary disease (COPD) in order to give quick symptom relief.